Memory Resources and Research Center Lille
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LEBOUVIER, Thibaud
CAFCA, NCT04570085: Effect of CAFfeine on Cognition in Alzheimer's Disease

Recruiting
3
248
Europe
Caffeine, Placebo
University Hospital, Lille, Groupement Interrégional de Recherche Clinique et d'Innovation, Laboratory of excellence DISTALZ, Région Nord-Pas de Calais, France, Meo coffee
Alzheimer Disease
11/24
11/24
NanoLi®_AD, NCT05423522: Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease

Recruiting
2
68
Europe
NanoLithium® NP03, Placebo
Medesis Pharma SA
Alzheimer's Disease
01/24
04/25
CELIA, NCT05399888: A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Recruiting
2
735
Europe, Canada, Japan, US, RoW
BIIB080, ISIS 814907, BIIB080-matching placebo
Biogen
Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
11/27
02/30
GENFI-LILLE, NCT04639622: GENetic Fronto Temporal Dementia Initiative in Lille

Recruiting
N/A
20
Europe
Investigation procedures
University Hospital, Lille
Frontotemporal Dementia
04/25
04/26
BIOWATCH, NCT05288842: Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

Recruiting
N/A
102
Europe
Lumbar puncture, blood sample
University Hospital, Lille, European Research Council
Alzheimer Disease, Frontotemporal Dementia
10/26
10/26
GliSyn, NCT05911178: Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease

Recruiting
N/A
90
Europe
[11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948, [11C]-PiB
Centre Hospitalier St Anne, Roche Pharma AG
Alzheimer Disease
02/28
04/28

Download Options